VASCORLEN 5 mg FILM-COATED TABLETS

2. What you need to know before you take Vascorlen

Do not takeVascorlen

• if you are allergic to ivabradine or any of the other ingredients of this medicine (listed in section 6);
• if your resting heart rate before treatment is too slow (below 70 beats per minute);
• if you have cardiogenic shock (a heart problem treated in the hospital);
• if you have a heart rhythm disorder;
• if you are having a heart attack;
• if you have very low blood pressure;
• if you have unstable angina (a severe type of angina that occurs very frequently with or without exertion);
• if you have recently worsened heart failure;
• if your heart rate is exclusively determined by your pacemaker;
• if you have severe liver problems;
• if you are taking medications for the treatment of fungal infections (such as ketoconazole, itraconazole), antibiotics of the macrolide group (such as josamycin, clarithromycin, telithromycin, or erythromycin administered orally), medications for the treatment of HIV infections (such as nelfinavir, ritonavir), or nefazodone (a medication for the treatment of depression) or diltiazem, verapamil (used for the treatment of high blood pressure or angina pectoris);
• if you are a woman of childbearing age and do not use reliable contraceptive methods;
• if you are pregnant or trying to become pregnant;
• if you are breastfeeding.

Warnings and precautions

Consult your doctor or pharmacist before starting to take Vascorlen:

• If you have heart rhythm disorders (such as irregular heartbeat, palpitations, increased chest pain) or sustained atrial fibrillation (a type of irregular heartbeat), or an anomaly in the electrocardiogram (ECG) called "QT prolongation syndrome".
• If you have symptoms such as fatigue, dizziness, or difficulty breathing (this may mean that your heart is beating too slowly).
• If you have symptoms of atrial fibrillation (unusually high resting pulse (above 110 beats per minute) or irregular, without any apparent reason, making it difficult to measure).
• If you have had a recent stroke (brain attack).
• If you have mild to moderate low blood pressure.
• If you have uncontrolled blood pressure, especially after a change in your antihypertensive treatment.
• If you have severe heart failure or heart failure with an ECG anomaly called "branch block".
• If you have chronic eye retinal disease.
• If you have moderate liver problems.
• If you have severe kidney problems.

If you meet any of these conditions, consult your doctor immediately before or during treatment with Vascorlen.

Children and adolescents

Vascorlen is not intended for use in children and adolescents under 18 years of age.

Using Vascorlen with other medicines

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.

Make sure to inform your doctor if you are taking any of the following medicines, as a dose adjustment of Vascorlen or monitoring may be necessary:

• fluconazole (an antifungal medication)
• rifampicin (an antibiotic)
• barbiturates (for sleep problems or epilepsy)
• phenytoin (for epilepsy)
• Hypericum perforatumor St. John's Wort (a medicinal plant for the treatment of depression).
• Medicines that prolong the QT interval for the treatment of heart rhythm disorders or other conditions:
• quinidine, disopyramide, ibutilide, sotalol, amiodarone (for the treatment of heart rhythm disorders)
• bepridil (for the treatment of angina pectoris)
• certain types of medications for the treatment of anxiety, schizophrenia, or other psychoses (such as pimozide, ziprasidone, sertindol)
• antimalarial medications (such as mefloquine or halofantrine)
• intravenous erythromycin (an antibiotic)
• pentamidine (an antiparasitic medication)
• cisapride (for gastroesophageal reflux).
• Some types of diuretics that can cause a reduction in potassium levels in the blood, such as furosemide, hydrochlorothiazide, indapamide (used to treat edema, high blood pressure).

Taking Vascorlen with food and drinks

Avoid grapefruit juice during treatment with Vascorlen.

Pregnancy

Do not take Vascorlen if you are pregnant or plan to become pregnant (see "Do not take Vascorlen").

If you are pregnant and have taken Vascorlen, consult your doctor.

Do not take Vascorlen if you are of childbearing age and do not use reliable contraceptive methods (see "Do not take Vascorlen").

Do not take Vascorlen if you are breastfeeding (see "Do not take Vascorlen"). Talk to your doctor if you are breastfeeding or plan to start breastfeeding, as breastfeeding should be interrupted if you are taking Vascorlen.

If you are pregnant, breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

Driving and using machines

Vascorlen may cause transient visual phenomena (a brief increase in brightness, usually caused by sudden changes in light intensity). If this happens, be careful when driving or using machinery in situations where sudden changes in light intensity may occur, especially when driving at night.

This medicine contains lactose

If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.

3. How to take Vascorlen

Follow exactly the administration instructions of this medicine indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.

Vascorlen should be taken with breakfast and dinner.

If you are being treated for stable angina pectoris

The initial dose should not exceed one Vascorlen 5 mg tablet twice a day. If you still have symptoms of angina and have tolerated the 5 mg twice-daily dose well, the dose may be increased. The maintenance dose should not exceed 7.5 mg twice a day. Your doctor will prescribe the correct dose for you. The usual dose is one tablet in the morning and one tablet in the evening. In some cases (e.g., if you are an elderly patient), your doctor may prescribe half the dose, i.e., half a Vascorlen 5 mg tablet (corresponding to 2.5 mg of ivabradine) in the morning and half a 5 mg tablet in the evening.

If you are being treated for chronic heart failure

The recommended initial dose is one Vascorlen 5 mg tablet twice a day, which may be increased if necessary to one Vascorlen 7.5 mg tablet twice a day. Your doctor will decide the suitable dose for you. The usual dose is one tablet in the morning and one tablet in the evening. In some cases (e.g., if you are an elderly patient), your doctor may prescribe half the dose, i.e., half a Vascorlen 5 mg tablet (corresponding to 2.5 mg of ivabradine) in the morning and half a 5 mg tablet in the evening.

The 5 mg tablet can be divided into equal doses.

If you take moreVascorlenthan you should

An overdose of Vascorlen may make you feel short of breath or tired because your heart is beating too slowly. If this happens, contact your doctor immediately.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service at 91 562 04 20, indicating the medication and the amount ingested.

If you forget to takeVascorlen

If you forget to take a dose of Vascorlen, take the next dose at the scheduled time. Do not take a double dose to make up for forgotten doses.

If you stop takingVascorlen

Generally, treatment for angina pectoris or chronic heart failure is for life, so you should consult your doctor before stopping this medication.

If you think the action of Vascorlen is too strong or too weak, tell your doctor or pharmacist.

If you have any other questions about the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The frequency of the possible side effects listed below is defined using the following system:

Very common: may affect more than 1 in 10 people.

Common: may affect up to 1 in 10 people.

Uncommon: may affect up to 1 in 100 people.

Rare: may affect up to 1 in 1,000 people.

Very rare: may affect up to 1 in 10,000 people.

Frequency not known: frequency cannot be estimated from the available data.

The most common side effects with this medicine are dose-dependent and related to its mechanism of action:

Very common:

Transient visual phenomena (brief moments of increased brightness, usually caused by sudden changes in light intensity). They can also be described as a halo, flashes of color, decomposition of the image, or multiple images. These usually appear during the first two months of treatment, after which they may occur repeatedly and resolve during or after treatment.

Common:

Modification of heart function (symptoms are a slowing of the heart rate). This occurs especially in the first 2 to 3 months after starting treatment.

Other side effects have also been reported:

Common:

Rapid irregular heart contraction, sensation of abnormal heartbeat, uncontrolled blood pressure, headache, dizziness, and blurred vision (cloudy vision).

Uncommon:

Palpitations and extra heartbeats, sensation of dizziness (nausea), constipation, diarrhea, abdominal pain, sensation of spinning (vertigo), difficulty breathing (dyspnea), muscle cramps, changes in laboratory tests: elevated blood uric acid levels, excess eosinophils (a type of white blood cell), and elevated creatinine levels in blood, skin rash, angioedema (such as inflammation of the face, tongue, or throat, difficulty breathing or swallowing), low blood pressure, fainting, feeling of tiredness, feeling of weakness, abnormal electrocardiogram, double vision, visual disturbance.

Rare:

Hives, itching, skin redness, malaise.

Very rare:

Irregular heartbeats.

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storing Vascorlen

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiration date that appears on the carton and blister after "EXP". The expiration date is the last day of the month indicated.

This medicine does not require special storage conditions.

Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE collection point in your pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.

6. Contents of the pack and other information

Composition of Vascorlen

• The active ingredient is ivabradine (as hydrochloride).

One film-coated tablet contains 5 mg of ivabradine (equivalent to 5.39 mg of ivabradine as hydrochloride).

• The other ingredients are:

Core of the tablet

Lactose monohydrate

Microcrystalline cellulose

Sodium croscarmellose

Anhydrous colloidal silica

Magnesium stearate

Coating

Hypromellose 6cp (E464)

Titanium dioxide (E171)

Macrogol 6000 (E1521)

Magnesium stearate (E470b)

Glycerol (E422)

Appearance of the product and contents of the pack

Film-coated tablet, white, oval, biconvex, with a score line and "5" engraved on one face, and smooth on the other.

The tablets are presented in aluminum/aluminum blisters of 14, 28, 56, 84, 98, 100, or 112 tablets.

Not all pack sizes may be marketed.

Marketing authorization holder and manufacturer

Marketing authorization holder

Biopharm Ltd.

5 Triaditza Str. Entrance A, Oborishte district,

Sofia 1000,

Bulgaria

Manufacturer

Genepharm S.A.

18 km Marathon Avenue

153 51 Pallini

Greece

You can request more information about this medicine by contacting the local representative of the marketing authorization holder:

Bluefish Pharma S.L.U.,

Ribera del Loira nº 46, Campo de las Naciones,

28042 Madrid,

Spain

This medicine is authorized in the Member States of the European Economic Area under the following names:

Date of last revision of this leaflet:April 2017

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/